Stevanato Group S.p.A. STVN

What this company does

The company provides drug containment, drug delivery and diagnostic solutions, as well as engineering solutions, to the pharmaceutical, biotechnology and life sciences industries. It operates 13 manufacturing plants, including ten plants for the manufacturing and assembly of bio-pharma and healthcare products in Italy, Germany, Slovakia, Brazil, Mexico, China and the United States, and three plants for the production of machinery and equipment in Italy and Denmark. As of December 31, 2025, the company employed 6,010 employees across multiple jurisdictions, with approximately 58% based in Italy. In 2025, its ten largest customers accounted for 53.6% of its consolidated revenue, and one customer accounted for 12% of consolidated revenue. The company's operations are organized into two reporting segments: Biopharmaceutical and Diagnostic Solutions, which covers products and services for the containment and delivery of pharmaceutical and biotechnology drugs and reagents as well as the production of diagnostic consumables, and Engineering, which covers equipment and technologies for pharmaceutical, biotechnology and life sciences manufacturing processes.

Written from the business description in Stevanato Group S.p.A.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.